5.45
price up icon0.18%   0.010
after-market 시간 외 거래: 5.43 -0.02 -0.37%
loading

Taysha Gene Therapies Inc (TSHA) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
13.73%
1.986
2.302 2.022 1.788 1.112
Operating Expenses
21.14%
28.74
23.72 21.95 27.69 22.41
Benefits Costs and Expenses
21.14%
28.87
23.83 20.81 - -
Costs And Expenses
21.14%
28.87
23.83 20.81 27.69 22.41
Operating Income/Loss
24.89%
-26.75
-21.42 -19.93 -25.90 -21.30
Nonoperating Income/Loss
19.44%
-0.129
-0.108 1.147 0.374 0.371
Income/Loss From Continuing Operations Before Tax
24.86%
-26.88
-21.53 -18.79 1.788 1.112
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
24.86%
-26.88
-21.53 -18.79 -25.52 -20.93
Net Income/Loss
24.86%
-26.88
-21.53 -18.79 -25.52 -20.93
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.65%
297.99
269.31 6.0824 267.82 232.82
Diluted Average Shares
10.65%
297.99
269.31 6.0824 267.82 232.82
Basic Earnings Per Share
12.50%
-0.09
-0.08 -0.07 -0.10 -0.09
Diluted Earnings Per Share
12.50%
-0.09
-0.08 -0.07 -0.10 -0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.43
price up icon 0.31%
$97.31
price down icon 0.33%
$31.50
price down icon 0.66%
$91.46
price down icon 0.15%
biotechnology ONC
$307.02
price up icon 0.32%
$166.55
price down icon 16.08%
자본화:     |  볼륨(24시간):